← Eichor
Study identifier: NCT05537389 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intravenous Neonatal Central Access Safety Trial

Condition: Newborn Complication · Catheter Complications  ·  Sponsor: University of Turin, Italy

PhaseNA
Planned participants736
Who can joinAll sexes, 1 Hour to 3 Months
Healthy volunteersNo

About this study

Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.

This description comes directly from the study's public registry record.

Talk to the study team

Francesco Cresi, PhD MD  ·  +390113135781  ·  incas@cresi.org

Elena Maggiora, MD  ·  +390113134437  ·  incas@cresi.org

Always discuss trial participation with your own doctor first.

Locations (1)

Città della Salute e della ScienzaTorino, Italia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05537389